Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

BackgroundPatients with liver cirrhosis have been excluded from randomized clinical trials of oral anticoagulation therapy for stroke prevention in atrial fibrillation. We hypothesized that patients with liver cirrhosis would have a positive net clinical benefit for oral anticoagulation when used fo...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Ling Kuo, Tze‐Fan Chao, Chia‐Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung, Tzeng‐Ji Chen, Gregory Y. H. Lip, Shih‐Ann Chen
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2017-11-01
Reeks:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Onderwerpen:	atrial fibrillation intracranial hemorrhage ischemic stroke liver cirrhosis
Online toegang:	https://www.ahajournals.org/doi/10.1161/JAHA.116.005307
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!